Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

55 Views

A1. Novel Agents

Poster Session: Novel Agents

(P-1185) Healthcare Resource Utilization (HCRU) of Critical Care Patients by Rank of Initiation from the Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam: Real-world Analysis (SPECTRA)

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Emre Yucel, PhD

Principal Scientist
Merck & Co., Inc.
North Wales, PA, United States

Co-Author(s)

AS

Alex Soriano, MD

Infectious Disease
Hospital Clínic de Barcelona
Barcelona, Catalonia, Spain
FT

Florian Thalhammer, MD

Infectious Disease specialist
Medizinische Universität Wien
Vienna, Wien, Austria
SK

Stefan Kluge, Prof. Dr. med.

Director
Department of Intensive Care, University Medical Center Hamburg-Eppendorf
Hamburg, Hamburg, Germany
PV

Pierluigi Viale, n/a

MD
Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico Sant'Orsola Malpighi, University of Bologna, Bologna, Italy
Bologna, Emilia-Romagna, Italy
MA

Mike Allen, PhD

Senior Medical Manager Antibiotics & AMR
MSD
London, England, United Kingdom
BA

Brune Akrich, MD

Associate Director Medical Affairs
Merck Research Labs, MSD
Puteaux, Ile-de-France, France
JL

Jessica Levy, n/a

Merck & Co., Ltd
Rahway, New Jersey, United States
HY

Huina Yang, MD, MBBS, FRCPath

Tan Tock Seng Hospital
Singapore, Singapore
SK

Sundeep Kaul, PHD FRCP FFICM

Dr
Harefield hospital
london, England, United Kingdom